Peter Altman bought $415 of BCDA
President and CEO at BioCardia, Inc.. 500 shares at an average of $0.83, traded Jul 17, 2026, filed Jul 20, 2026.
Score components
- +25RoleCEO
- 0Trade size$415 at market
- -5Relative to holdingsUnder 1% of holdings (0.1%)
- +18Price context4% above the 52-week low; 65% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- +5Repeat buying11 buys in 90 days
- -5Track recordMedian 6-month excess return -42% over 26 past buys
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001437749-26-023868, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jul 17, 2026 | POpen-market purchase Common Stock | +500 | $0.83 | $415 | 368,885 | Jul 20, 2026 |
Related signals
Other insiders at BioCardia, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 33Weak | BCDAbuy BioCardia, Inc. | Peter Altman President and CEO | $1,030 1,000 shares | +0% | |
| 33Weak | BCDAbuy BioCardia, Inc. | Peter Altman President and CEO | $1,995 1,900 shares | +0% | |
| 28Weak | BCDAbuy BioCardia, Inc. | Peter Altman President and CEO | $872 800 shares | +0% | |
| 33Weak | BCDAbuy BioCardia, Inc. | Peter Altman President and CEO | $5,022 5,400 shares | +1% | |
| 28Weak | BCDAbuy BioCardia, Inc. | Peter Altman President and CEO | $1,748 1,900 shares | +1% | |
| 43Moderate | BCDAbuy BioCardia, Inc. | Peter Altman President and CEO | $3,900 5,000 shares | +1% | |
| 43Moderate | BCDAbuy BioCardia, Inc. | Peter Altman President and CEO | $3,754 4,300 shares | +1% | |
| 33Weak | BCDAbuy BioCardia, Inc. | Peter Altman President and CEO | $7,175 7,500 shares | +2% | |
| 33Weak | BCDAbuy BioCardia, Inc. | Peter Altman President and CEO | $5,208 5,400 shares | +2% | |
| 51Moderate | BioCardia, Inc. | Simon H Stertzer director | $104k 109,200 shares | +191% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.